“The Impact of Tralokinumab on Quality of Life and School in Patients Aged 12-17 With Atopic Dermatitis: Results from the Phase 3 ECZTRA 6 Trial”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 2, Mar. 2023, p. s139, https://doi.org/10.25251/skin.7.supp.139.